We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Postpones Capitol Hill Meetings on User Fees, Pending White House Review
FDA Postpones Capitol Hill Meetings on User Fees, Pending White House Review
The FDA had to postpone meetings with Capitol Hill staff to discuss upcoming user fee legislation, after the Trump Administration directed agencies to halt correspondence with members of Congress.